---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-22-002256"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2022-02-18T23:59:59+00:00"
generated_at: "2026-06-27T06:33:59.461667+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharmaceuticals director Dr. Daniel Goodman will not stand for reelection at 2022 annual meeting

## Summary
- Dr. Daniel Goodman notified Tonix on Feb 16, 2022, of his decision not to stand for reelection.
- He will continue as director and retain committee memberships through the 2022 Annual Meeting.
- No replacement director has been announced; the 2022 Annual Meeting date is not specified.

## SEC filing metadata
- accession: 0001387131-22-002256
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2022-02-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000138713122002256/0001387131-22-002256-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000138713122002256/tnxp-8k_021622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-22-002256
- JSON: https://secwatch.observer/filing/0001387131-22-002256.json
- Plain text: https://secwatch.observer/filing/0001387131-22-002256.txt

## Key facts
- Executive change
  Daniel Goodman departed as Director at Tonix Pharmaceuticals Holding Corp..
  - Action: not stand for reelection
  - Role: Director
  source text: Dr. Daniel Goodman provided notice to Tonix Pharmaceuticals Holding Corp. (the “Company”) of his intention not to stand for reelection at the Company’s 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713122002256/0001387131-22-002256-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.